Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 26: 1266-1271, 1980;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ellis, G.
Right arrow Articles by Goldberg, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ellis, G.
Right arrow Articles by Goldberg, D. M.

Clinical Chemistry, Vol 26, 1266-1271, Copyright © 1980 by American Association for Clinical Chemistry

Further experience with computer-assisted diagnosis of diseases of the liver and biliary tree

G Ellis, E Worthy and DM Goldberg

Computer-assisted classification of disease has largely relied upon testing the diagnostic algorithm in the same population from which it was originally derived, as a means of validation. To evaluate the accuracy of a diagnostic program in which discriminant function analysis is used, we applied it to a separate population, selected by different criteria from those used to define the original case material on which the diagnostic program was based. We selected a group of 315 patients having abnormal values for alkaline phosphatase, bilirubin, or aspartate aminotransferase for further biochemical and immunological investigations. We used a computer program involving discriminant function analysis and classification procedures primed with the results of 10 tests obtained on each of 535 patients in a previous series to allocate those 173 new patients who had diseases of the liver or biliary tree into one of 13 disease groups. The classification was less accurate than was the case in previous cross-validation studies. We developed new discriminants with the new case material, using the same group of tests, and when cross-validation was performed, overall accuracy was greatly improved. These experiences point to the powerful influence of group selection upon computer-assisted diagnostic procedures, and the hazards of applying to one clinical population discriminant functions derived from a different population.


The following articles in journals at HighWire Press have cited this article:


Home page
American Behavioral ScientistHome page
D. M. GOLDBERG
Discriminant Function Analysis: Application to Liver Disease
American Behavioral Scientist, May 1, 1982; 25(5): 545 - 556.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by the American Association for Clinical Chemistry.